Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (947) 947
Publication (32) 32
Newsletter (30) 30
Book Review (27) 27
Newspaper Article (10) 10
Book Chapter (7) 7
Magazine Article (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pimecrolimus (683) 683
humans (544) 544
dermatology (459) 459
index medicus (338) 338
atopic dermatitis (325) 325
tacrolimus (312) 312
tacrolimus - analogs & derivatives (284) 284
female (254) 254
male (227) 227
calcineurin inhibitors (216) 216
dermatitis, atopic - drug therapy (212) 212
tacrolimus - therapeutic use (194) 194
adult (192) 192
double-blind (181) 181
administration, topical (179) 179
tacrolimus - administration & dosage (176) 176
treatment outcome (158) 158
skin (155) 155
atopic-dermatitis (152) 152
tacrolimus ointment (149) 149
children (145) 145
efficacy (145) 145
pimecrolimus cream 1-percent (142) 142
middle aged (136) 136
dermatitis (127) 127
child (126) 126
eczema (120) 120
safety (115) 115
tacrolimus - adverse effects (110) 110
corticosteroids (105) 105
dermatologic agents - therapeutic use (105) 105
administration, cutaneous (104) 104
immunosuppressive agents - therapeutic use (100) 100
skin diseases (100) 100
long-term management (99) 99
adolescent (98) 98
drug therapy (93) 93
pimecrolimus cream (89) 89
topical calcineurin inhibitors (88) 88
animals (85) 85
immunosuppressive agents - administration & dosage (83) 83
severity of illness index (83) 83
dermatologic agents - administration & dosage (82) 82
care and treatment (79) 79
aged (78) 78
allergy (70) 70
child, preschool (69) 69
pharmacology & pharmacy (65) 65
ointments (64) 64
psoriasis (64) 64
antiinflammatory drug (62) 62
immunology (62) 62
management (62) 62
medicine & public health (62) 62
double-blind method (61) 61
therapy (60) 60
sdz asm 981 (59) 59
topical corticosteroids (58) 58
quality-of-life (56) 56
tacrolimus - pharmacology (55) 55
young adult (55) 55
health aspects (53) 53
infants (53) 53
quality of life (53) 53
immunosuppressive agents - adverse effects (52) 52
vitiligo (51) 51
dermatologic agents - adverse effects (50) 50
treatment (49) 49
adrenal cortex hormones - therapeutic use (48) 48
clinical trials (48) 48
analysis (47) 47
infant (46) 46
adult patients (44) 44
follow-up studies (44) 44
pediatrics (44) 44
topical tacrolimus (44) 44
inflammation (42) 42
risk factors (42) 42
calcineurin (41) 41
diagnosis (41) 41
pharmacology/toxicology (41) 41
pharmacotherapy (41) 41
sdz asm-981 (41) 41
topical pimecrolimus (41) 41
dermatitis, atopic - therapy (39) 39
randomized controlled trials as topic (38) 38
cream (37) 37
atopic eczema (36) 36
calcineurin inhibitor (36) 36
cyclosporine (36) 36
dose-response relationship, drug (36) 36
medicine, general & internal (36) 36
pruritus (36) 36
research (36) 36
skin - drug effects (36) 36
dermatitis, atopic - diagnosis (35) 35
dermatitis, atopic - immunology (35) 35
skin - pathology (35) 35
1-percent (34) 34
elidel (34) 34
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (849) 849
German (56) 56
Korean (22) 22
French (19) 19
Polish (19) 19
Turkish (14) 14
Spanish (9) 9
Portuguese (3) 3
Russian (3) 3
Italian (2) 2
Czech (1) 1
Dutch (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Improving the drug selection and development process for combination devices
by Hupcey, Maggie A.Z and Ekins, Sean
Drug Discovery Today, ISSN 1359-6446, 2007, Volume 12, Issue 19, pp. 844 - 852
Combination devices are at the interface of both pharmaceutical and medical device research. While there have been several notable successes in bringing... 
ELUTING STENTS | CYTOCHROME-P450 | BIOCOMPATIBILITY | COST-EFFECTIVENESS | INHIBITION | CONTROLLED-RELEASE | RESTENOSIS | MUSCLE | PHARMACOLOGY & PHARMACY | IMPLANTS | DELIVERY | Drug Delivery Systems - instrumentation | Prostheses and Implants - adverse effects | Drug Industry | Drug Implants | Pharmaceutical Preparations - administration & dosage | Equipment Design | Research Design | Drug Delivery Systems - adverse effects | Drug-Eluting Stents - adverse effects | Technology Assessment, Biomedical
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
by Kimball, AB and Gordon, KB and Fakharzadeh, S and Yeilding, N and Szapary, PO and Schenkel, B and Guzzo, C and Li, S and Papp, KA
BRITISH JOURNAL OF DERMATOLOGY, ISSN 0007-0963, 04/2012, Volume 166, Issue 4, pp. 861 - 872
Background An unmet need remains for safe and effective long-term treatments of psoriasis. Objectives To evaluate ustekinumab efficacy and safety for up to 3... 
ATOPIC-DERMATITIS | SAFETY | PIMECROLIMUS CREAM | TACROLIMUS OINTMENT | INDEX | DERMATOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text ORIGINAL ARTICLE : A Pilot Study of 1% Pimecrolimus Cream for the Treatment of Childhood Segmental Vitiligo
by Woo Haing Shim and and Sung Won Suh and Seung Wook Jwa and Margaret Song and Hoon Soo Kim and Hyun Chang Ko and Byung Soo Kim and Moon Bum Kim
Annals of Dermatology, ISSN 1013-9087, 2013, Volume 25, Issue 2, p. 168
There is as yet no effective and safe treatment for vitiligo. One percent pimecrolimus cream, a topical calcineurin inhibitor, has been tried for the treatment... 
Pimecrolimus | Vitiligo
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Efficacy of combination therapy of pimecrolimus 1% cream and mometasone cream with either agent alone in the treatment of childhood vitiligo
Journal of Pakistan Association of Dermatologists, ISSN 1560-9014, 12/2018, Volume 28, Issue 4, p. 507
Autoimmunity | Pimecrolimus | Patient compliance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies
by Eichenfield, Lawrence F and Tom, Wynnis L and Berger, Timothy G and Krol, Alfons and Paller, Amy S and Schwarzenberger, Kathryn and Bergman, James N and Chamlin, Sarah L and Cohen, David E and Cooper, Kevin D and Cordoro, Kelly M and Davis, Dawn M and Feldman, Steven R and Hanifin, Jon M and Margolis, David J and Silverman, Robert A and Simpson, Eric L and Williams, Hywel C and Elmets, Craig A and Block, Julie and Harrod, Christopher G and Begolka, Wendy Smith and Sidbury, Robert and Work Grp
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 71, Issue 1, pp. 116 - 132
Atopic dermatitis is a common and chronic, pruritic inflammatory skin condition that can affect all age groups. This evidence-based guideline addresses... 
bathing | corticosteroids | antihistamines | emollients | atopic dermatitis | topicals | wet wraps | antimicrobials | calcineurin inhibitors | ALLERGIC CONTACT-DERMATITIS | PIMECROLIMUS CREAM 1-PERCENT | RANDOMIZED CONTROLLED-TRIAL | TACROLIMUS OINTMENT | WET-WRAP DRESSINGS | DERMATOLOGY | LONG-TERM MANAGEMENT | PEDIATRIC-PATIENTS | DOUBLE-BLIND | STAPHYLOCOCCUS-AUREUS | Calcineurin Inhibitors | Emollients - therapeutic use | Dermatitis, Atopic - drug therapy | Humans | Histamine Antagonists - administration & dosage | Dermatitis, Atopic - therapy | Evidence-Based Medicine | Administration, Topical | Chronic Disease | Adrenal Cortex Hormones - administration & dosage | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Case Reports : Successful Treatment of Cutaneous Lesions of Dermatomyositis with Topical Pimecrolimus
by Ji Eun Kim and and Myeong Gil Jeong and Ha Eun Lee and Joo Yeon Ko and Young Suck Ro
Annals of Dermatology, ISSN 1013-9087, 2011, Volume 23, Issue 3, p. 348
Dermatomyositis (DM) is an idiopathic inflammatory process characterized by proximal muscle weakness and cutaneous lesions, such as the Gottron`s sign,... 
Pimecrolimus | Dermatomyositis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pimecrolimus versus Placebo in Minor, Recurrent Aphthous Stomatitis: A Randomized Double-blind Controlled Trial
by Ayda Moghaddas and Azadeh Moghaddas and AmirHossein Siadat and Giti Sadeghian
Journal of Pharmaceutical Care, ISSN 2322-4630, 10/2015, Volume 2, Issue 1, pp. 10 - 14
Background: Oral aphthous is one of the most common oral mucosal inflammatory disorders which are very painful. There is no definite medical strategy up to now... 
Aphthous Stomatitis Pimecrolimus Immunomodulation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Calcineurin Inhibitors in Pediatric Atopic Dermatitis
: A Review of Current Evidence
by Kalavala, Manjunatha and Dohil, Magdalene A
American Journal of Clinical Dermatology, ISSN 1175-0561, 2/2011, Volume 12, Issue 1, pp. 15 - 24
Atopic dermatitis (AD) is a common, chronic inflammatory dermatosis with a prevalence of 7–21% in school-aged children. Childhood AD has a profound impact on... 
Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | Calcineurin-inhibitors, therapeutic use | Pimecrolimus, therapeutic use | Pimecrolimus, adverse reactions | Tacrolimus, adverse reactions | Tacrolimus, therapeutic use | Topical | Atopic-dermatitis, treatment | Children | Calcineurin-inhibitors, adverse reactions | LONG-TERM MANAGEMENT | CONTROLLED-TRIAL | STAPHYLOCOCCAL COLONIZATION | COLLAGEN-SYNTHESIS | PIMECROLIMUS CREAM 1-PERCENT | TOPICAL TACROLIMUS | TACROLIMUS OINTMENT | HYDROCORTISONE ACETATE | SAFETY PROFILE | LANGERHANS CELLS | DERMATOLOGY | Complications and side effects | Pimecrolimus | Tacrolimus | Atopic dermatitis | Calcineurin | Patient outcomes | Dosage and administration | Diagnosis | Drug therapy | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Topische Calcineurininhibitoren bei der Behandlung der atopischen Dermatitis - Fragen zur Sicherheit: Ein Update
by Czarnecka-Operacz, Magdalena and Jenerowicz, Dorota
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 03/2012, Volume 10, Issue 3, pp. 167 - 173
safety | tacrolimus | atopic dermatitis | pimecrolimus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Modulation of Atopy Patch Test and Skin Prick Test by Pretreatment with 1% Pimecrolimus Cream
by Weissenbacher, Stephanie and Traidl-Hoffmann, Claudia and Eyerich, Kilian and Katzer, Kerstin and Braeutigam, Matthias and Loeffler, Helena and Hofmann, Heidelore and Behrendt, Heidrun and Ring, Johannes and Darsow, Ulf
International Archives of Allergy and Immunology, ISSN 1018-2438, 06/2006, Volume 140, Issue 3, pp. 239 - 244
Background: In a subgroup of patients with atopic eczema (AE), aeroallergens are relevant eliciting factors. The atopy patch test (APT) was proposed as... 
Original Paper | Pimecrolimus | Atopic eczema | Atopy patch test | BASOPHILS | ALLERGY | DERMATITIS | ECZEMA | MAST-CELLS | atopy patch test | RELEASE | IMMUNOLOGY | atopic eczema | pimecrolimus | Immunohistochemistry | Allergens - adverse effects | Cats | Double-Blind Method | Humans | Middle Aged | Male | Patch Tests - methods | Tacrolimus - analogs & derivatives | Immunoglobulin E - blood | Dermatitis, Atopic - diagnosis | Animals | Allergens - immunology | Dermatitis, Atopic - immunology | Statistics, Nonparametric | Tacrolimus - pharmacology | Adult | Female | Skin Tests - methods | Biopsy, Needle | Cytokines - immunology | Dermatologic Agents - pharmacology | Pyroglyphidae - immunology | Skin diseases | Medical tests | Eczema
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Systematic review of published trials: Long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
by Siegfried, Elaine C and Jaworski, Jennifer C and Kaiser, Jennifer D and Hebert, Adelaide A
BMC Pediatrics, ISSN 1471-2431, 06/2016, Volume 16, Issue 1, p. 75
Background: Many clinicians have concerns about the safety of atopic dermatitis (AD) treatments, particularly in children requiring long-term daily maintenance... 
Pimecrolimus | Tacrolimus | Topical corticosteroid | Atopic dermatitis | TCS | Long-term safety | TCI | Lymphoma | Pediatric | Topical calcineurin inhibitor | TACROLIMUS 0.03-PERCENT OINTMENT | EFFICACY | PIMECROLIMUS CREAM 1-PERCENT | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | FLARE-PROGRESSION | CHILDREN | TASK-FORCE | PEDIATRICS | QUALITY-OF-LIFE | PERCUTANEOUS-ABSORPTION | Adrenal Cortex Hormones - adverse effects | Calcineurin Inhibitors - adverse effects | Dermatitis, Atopic - drug therapy | Calcineurin Inhibitors - therapeutic use | Humans | Treatment Outcome | Dermatologic Agents - therapeutic use | Administration, Cutaneous | Adrenal Cortex Hormones - therapeutic use | Child | Dermatologic Agents - adverse effects | Complications and side effects | Corticosteroids | Dosage and administration | Research | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
by Ring, J and Alomar, A and Bieber, T and Deleuran, M and Fink‐Wagner, A and Gelmetti, C and Gieler, U and Lipozencic, J and Luger, T and Oranje, A.P and Schäfer, T and Schwennesen, T and Seidenari, S and Simon, D and Ständer, S and Stingl, G and Szalai, S and Szepietowski, J.C and Taïeb, A and Werfel, T and Wollenberg, A and Darsow, U and ESPD and EFA and EDF and Global Allergy Asthma European Net and EADV and ETFAD and European Dermatology Forum (EDF) and European Society of Pediatric Dermatology (ESPD) and European Task Force on Atopic Dermatitis (ETFAD) and Global Allergy and Asthma European Network (GA2LEN) and European Academy of Dermatology and Venereology (EADV) and European Federation of Allergy (EFA)
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 08/2012, Volume 26, Issue 8, pp. 1045 - 1060
The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and... 
0.1-PERCENT TACROLIMUS OINTMENT | TESTING ENHANCES IDENTIFICATION | PIMECROLIMUS CREAM 1-PERCENT | DOUBLE-BLIND | STAPHYLOCOCCUS-AUREUS | SKIN BARRIER FUNCTION | TOPICAL CALCINEURIN INHIBITORS | WET-WRAP DRESSINGS | LONG-TERM TREATMENT | SILVER-COATED TEXTILES | DERMATOLOGY | Dermatologic Agents - therapeutic use | Dermatitis, Atopic - drug therapy | Humans | Practice Guidelines as Topic | Food allergy | Medical colleges | Corticosteroids | Nutrition | Dermatology | Psychotherapy | Dermatologic agents | Requirements | Tacrolimus | Atopic dermatitis | Immunotherapy | Eczema | Formulae, receipts, prescriptions | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Current views on the pathogenesis and principles of external treatment of atopic dermatitis in children
by Murashkin, Nikolay N and Materikin, Alexander I and Ambarchyan, Eduard T and Epishev, Roman V
Voprosy Sovremennoi Pediatrii - Current Pediatrics, ISSN 1682-5527, 2016, Volume 15, Issue 6, pp. 584 - 589
The article analyzes the current data on the pathogenesis of atopic dermatitis. It discusses the role of the damaged dermal barrier structure in the... 
Atopic dermatitis | Pimecrolimus | Children | children | atopic dermatitis | pimecrolimus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Allergic contact dermatitis caused by mupirocin and pimecrolimus
by Zhang, Amy J and Warshaw, Erin M
Contact Dermatitis, ISSN 0105-1873, 02/2019, Volume 80, Issue 2, pp. 132 - 133
Elidel | case report | allergic contact dermatitis | pimecrolimus | mupirocin | ALLERGY | TACROLIMUS | DERMATOLOGY | Contact dermatitis | Dermatitis | Mupirocin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
by Wollenberg, A and Oranje, A and Deleuran, M and Simon, D and Szalai, Z and Kunz, B and Svensson, A and Barbarot, S and von Kobyletzki, L and Taieb, A and de Bruin-Weller, M and Werfel, T and Trzeciak, M and Vestergard, C and Ring, J and Darsow, U and European Task Force Atopic and European Task Force on Atopic Dermatitis/EADV Eczema Task Force and the European Task Force on Atopic Dermatitis/EADV Eczema Task Force and Lund University and Dermatologi och venereologi, Lund and Lunds universitet and Department of Dermatology and Venereology (Lund)
JEADV : journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 2016, Volume 30, Issue 5, pp. 729 - 747
Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using... 
Dermatitis, Atopic | Adult | Child | Humans | Journal Article | Practice Guideline | MAINTENANCE TREATMENT | ANTI-CD20 RITUXIMAB TREATMENT | INTRAVENOUS IMMUNOGLOBULIN | PIMECROLIMUS CREAM 1-PERCENT | DOUBLE-BLIND | STAPHYLOCOCCUS-AUREUS COLONIZATION | ALLERGEN-SPECIFIC IMMUNOTHERAPY | TACROLIMUS OINTMENT | TOPICAL CALCINEURIN INHIBITORS | LONG-TERM TREATMENT | DERMATOLOGY | Dermatitis, Atopic - radiotherapy | Dermatitis, Atopic - drug therapy | Dermatitis, Atopic - therapy | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Dermatologi och venereologi | Dermatology and Venereal Diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights